Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition

J Allergy Clin Immunol. 2010 Aug;126(2):400-3. doi: 10.1016/j.jaci.2010.05.020.
No abstract available

Publication types

  • Letter

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Administration, Topical
  • Animals
  • Benzamides / pharmacology*
  • Cell Line
  • Cyclohexanones / pharmacology*
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / immunology
  • Dermatitis, Atopic / metabolism*
  • Dermatitis, Atopic / pathology
  • Disease Models, Animal
  • Humans
  • Mice
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism*

Substances

  • Benzamides
  • Cyclohexanones
  • NF-kappa B
  • dehydroxymethylepoxyquinomicin